Improving outcomes in carcinoid heart disease - learning from a single centre.

Introduction: A significant proportion of patients with carcinoid syndrome develop carcinoid heart disease (CHD). Valve degeneration can lead to right heart failure, and worsening prognosis. Replacement of affected valves is an effective therapy.

Regarding "TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World".

This letter to the editor, regarding the reported results of the TELEPRO study by Strosberg et al., provides real‐world support of the benefit of telotristat ethyl for symptoms of carcinoid syndrome.

Non-motor correlates of wrist-worn wearable sensor use in Parkinson's disease: an exploratory analysis.

Wearable sensors are becoming increasingly more available in Parkinson's disease and are used to measure motor function. Whether non-motor symptoms (NMS) can also be measured with these wearable sensors remains unclear. We therefore performed a retrospective, exploratory, analysis of 108 patients with a diagnosis of idiopathic Parkinson's disease enroled in the Non-motor Longitudinal International Study (UKCRN No.